Skip to main content
. 2018 Mar 12;15(5):4557–4563. doi: 10.3892/etm.2018.5947

Figure 4.

Figure 4.

Expression of miR-381 in the (A) plaque tissues, (B) PBMCs and (C) serum of healthy subjects and patients with coronary atherosclerosis. Reverse transcription-quantitative polymerase chain reaction was used to determine the expression of miR-381. *P<0.05 and **P<0.01 vs. the control group. COX-2, cyclooxygenase-2; PBMCs, peripheral blood mononuclear cells; miR, microRNA.